Core Viewpoint - The company, Tuoxin Pharmaceutical, is committed to research, production, and sales in the pharmaceutical and health sector, with a diversified business layout covering APIs, pharmaceutical intermediates, and functional food ingredients [1] Group 1: Business Operations - The company has established a wide product line that serves key health areas such as antiviral, antitumor, neurological medications, and functional foods [1] - Tuoxin Pharmaceutical's subsidiary, Xinxiang Pharmaceutical, is producing and supplying Ribavirin API in a large-scale and stable manner to meet the public health demand during the current flu outbreak [1] Group 2: Market Demand and Supply - Ribavirin is recognized as a broad-spectrum and potent antiviral drug, serving as a key component in related antiviral medications [1] - The sufficient supply of APIs from the company provides critical support for downstream formulation companies in producing flu treatment drugs, effectively addressing the medication demand during the flu peak [1] Group 3: Future Developments - The company is actively pursuing the development of new antiviral drugs targeting influenza, aiming to meet future market demands [1]